Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Revised protocol of extracorporeal membrane oxygenation (ECMO) therapy in severe ARDS. Recommendations of the Veno-venous ECMO Expert Panel appointed in February 2016 by the national consultant on anesthesiology and intensive care.

Identifieur interne : 000399 ( PubMed/Curation ); précédent : 000398; suivant : 000400

Revised protocol of extracorporeal membrane oxygenation (ECMO) therapy in severe ARDS. Recommendations of the Veno-venous ECMO Expert Panel appointed in February 2016 by the national consultant on anesthesiology and intensive care.

Auteurs : Romuald Lango [Pologne] ; Zbigniew Szkulmowski ; Dariusz Maciejewski ; Andrzej Sosnowski ; Krzysztof Kusza

Source :

RBID : pubmed:28643320

Descripteurs français

English descriptors

Abstract

Extracorporeal Membrane Oxygenation (ECMO) has become well established technique of the treatment of severe acute respiratory failure (Veno-Venous ECMO) or circulatory failure (Veno-Arterial ECMO) which enables effective blood oxygenation and carbon dioxide removal for several weeks. Veno-Venous ECMO (V-V ECMO ) is a lifesaving treatment of patients in whom severe ARDS makes artificial lung ventilation unlikely to provide satisfactory blood oxygenation for preventing further vital organs damage and progression to death. The protocol below regards exclusively veno-venous ECMO treatment as a support for blood gas conditioning by means of extracorporeal circuit in adult patients with severe ARDS. V-V ECMO does not provide treatment for acutely and severely diseased lungs, but it enables patient to survive the critical phase of severe ARDS until recovery of lung function. Besides avoiding patients death from hypoxemia, this technique can also prevent further progression of the lung damage due to artificial ventilation. Recent experience of ECMO treatment since the outbreak of AH1N1 influenza pandemic in 2009, along with technical progress and advancement in understanding pathophysiology of ventilator-induced lung injury, have contributed to significant improvement of the results of ECMO treatment. Putative factors related to increased survival include patients retrieval after connecting them to ECMO, and less intensive anticoagulation protocols. The aim of presenting this revised protocol was to improve the effects of ECMO treatment in patients with severe ARDS, to enhance ECMO accessibility for patients who might possibly benefit from this treatment, to reduce time until patient's connection to ECMO, and to avoid ECMO treatment in futile cases. The authors believe that this protocol, based on recent papers and their own experience, can provide help and advice both for the centers which develop V-V ECMO program, and for doctors who will refer their patients for the treatment in an ECMO center.

DOI: 10.5603/AIT.a2017.0028
PubMed: 28643320

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:28643320

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Revised protocol of extracorporeal membrane oxygenation (ECMO) therapy in severe ARDS. Recommendations of the Veno-venous ECMO Expert Panel appointed in February 2016 by the national consultant on anesthesiology and intensive care.</title>
<author>
<name sortKey="Lango, Romuald" sort="Lango, Romuald" uniqKey="Lango R" first="Romuald" last="Lango">Romuald Lango</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Cardioanaesthesiology, Medical University of Gdańsk, Gdańsk, Poland. rlango@gumed.edu.pl.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Department of Cardioanaesthesiology, Medical University of Gdańsk, Gdańsk</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Szkulmowski, Zbigniew" sort="Szkulmowski, Zbigniew" uniqKey="Szkulmowski Z" first="Zbigniew" last="Szkulmowski">Zbigniew Szkulmowski</name>
</author>
<author>
<name sortKey="Maciejewski, Dariusz" sort="Maciejewski, Dariusz" uniqKey="Maciejewski D" first="Dariusz" last="Maciejewski">Dariusz Maciejewski</name>
</author>
<author>
<name sortKey="Sosnowski, Andrzej" sort="Sosnowski, Andrzej" uniqKey="Sosnowski A" first="Andrzej" last="Sosnowski">Andrzej Sosnowski</name>
</author>
<author>
<name sortKey="Kusza, Krzysztof" sort="Kusza, Krzysztof" uniqKey="Kusza K" first="Krzysztof" last="Kusza">Krzysztof Kusza</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28643320</idno>
<idno type="pmid">28643320</idno>
<idno type="doi">10.5603/AIT.a2017.0028</idno>
<idno type="wicri:Area/PubMed/Corpus">000399</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000399</idno>
<idno type="wicri:Area/PubMed/Curation">000399</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000399</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Revised protocol of extracorporeal membrane oxygenation (ECMO) therapy in severe ARDS. Recommendations of the Veno-venous ECMO Expert Panel appointed in February 2016 by the national consultant on anesthesiology and intensive care.</title>
<author>
<name sortKey="Lango, Romuald" sort="Lango, Romuald" uniqKey="Lango R" first="Romuald" last="Lango">Romuald Lango</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Cardioanaesthesiology, Medical University of Gdańsk, Gdańsk, Poland. rlango@gumed.edu.pl.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Department of Cardioanaesthesiology, Medical University of Gdańsk, Gdańsk</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Szkulmowski, Zbigniew" sort="Szkulmowski, Zbigniew" uniqKey="Szkulmowski Z" first="Zbigniew" last="Szkulmowski">Zbigniew Szkulmowski</name>
</author>
<author>
<name sortKey="Maciejewski, Dariusz" sort="Maciejewski, Dariusz" uniqKey="Maciejewski D" first="Dariusz" last="Maciejewski">Dariusz Maciejewski</name>
</author>
<author>
<name sortKey="Sosnowski, Andrzej" sort="Sosnowski, Andrzej" uniqKey="Sosnowski A" first="Andrzej" last="Sosnowski">Andrzej Sosnowski</name>
</author>
<author>
<name sortKey="Kusza, Krzysztof" sort="Kusza, Krzysztof" uniqKey="Kusza K" first="Krzysztof" last="Kusza">Krzysztof Kusza</name>
</author>
</analytic>
<series>
<title level="j">Anaesthesiology intensive therapy</title>
<idno type="eISSN">1731-2531</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Anesthesiology</term>
<term>Carbon Dioxide (blood)</term>
<term>Critical Care (methods)</term>
<term>Extracorporeal Membrane Oxygenation (methods)</term>
<term>Humans</term>
<term>Oxygen (blood)</term>
<term>Practice Guidelines as Topic</term>
<term>Respiration, Artificial (methods)</term>
<term>Respiratory Distress Syndrome, Adult (therapy)</term>
<term>Ventilator-Induced Lung Injury (physiopathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Anesthésiologie</term>
<term>Dioxyde de carbone (sang)</term>
<term>Guides de bonnes pratiques cliniques comme sujet</term>
<term>Humains</term>
<term>Lésion pulmonaire induite par la ventilation mécanique (physiopathologie)</term>
<term>Oxygène (sang)</term>
<term>Oxygénation extracorporelle sur oxygénateur à membrane ()</term>
<term>Soins de réanimation ()</term>
<term>Syndrome de détresse respiratoire de l'adulte ()</term>
<term>Ventilation artificielle ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Carbon Dioxide</term>
<term>Oxygen</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Critical Care</term>
<term>Extracorporeal Membrane Oxygenation</term>
<term>Respiration, Artificial</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr">
<term>Lésion pulmonaire induite par la ventilation mécanique</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Ventilator-Induced Lung Injury</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Dioxyde de carbone</term>
<term>Oxygène</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Respiratory Distress Syndrome, Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Anesthesiology</term>
<term>Humans</term>
<term>Practice Guidelines as Topic</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Anesthésiologie</term>
<term>Guides de bonnes pratiques cliniques comme sujet</term>
<term>Humains</term>
<term>Oxygénation extracorporelle sur oxygénateur à membrane</term>
<term>Soins de réanimation</term>
<term>Syndrome de détresse respiratoire de l'adulte</term>
<term>Ventilation artificielle</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Extracorporeal Membrane Oxygenation (ECMO) has become well established technique of the treatment of severe acute respiratory failure (Veno-Venous ECMO) or circulatory failure (Veno-Arterial ECMO) which enables effective blood oxygenation and carbon dioxide removal for several weeks. Veno-Venous ECMO (V-V ECMO ) is a lifesaving treatment of patients in whom severe ARDS makes artificial lung ventilation unlikely to provide satisfactory blood oxygenation for preventing further vital organs damage and progression to death. The protocol below regards exclusively veno-venous ECMO treatment as a support for blood gas conditioning by means of extracorporeal circuit in adult patients with severe ARDS. V-V ECMO does not provide treatment for acutely and severely diseased lungs, but it enables patient to survive the critical phase of severe ARDS until recovery of lung function. Besides avoiding patients death from hypoxemia, this technique can also prevent further progression of the lung damage due to artificial ventilation. Recent experience of ECMO treatment since the outbreak of AH1N1 influenza pandemic in 2009, along with technical progress and advancement in understanding pathophysiology of ventilator-induced lung injury, have contributed to significant improvement of the results of ECMO treatment. Putative factors related to increased survival include patients retrieval after connecting them to ECMO, and less intensive anticoagulation protocols. The aim of presenting this revised protocol was to improve the effects of ECMO treatment in patients with severe ARDS, to enhance ECMO accessibility for patients who might possibly benefit from this treatment, to reduce time until patient's connection to ECMO, and to avoid ECMO treatment in futile cases. The authors believe that this protocol, based on recent papers and their own experience, can provide help and advice both for the centers which develop V-V ECMO program, and for doctors who will refer their patients for the treatment in an ECMO center.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">28643320</PMID>
<DateCompleted>
<Year>2018</Year>
<Month>03</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>05</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1731-2531</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>49</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2017</Year>
</PubDate>
</JournalIssue>
<Title>Anaesthesiology intensive therapy</Title>
<ISOAbbreviation>Anaesthesiol Intensive Ther</ISOAbbreviation>
</Journal>
<ArticleTitle>Revised protocol of extracorporeal membrane oxygenation (ECMO) therapy in severe ARDS. Recommendations of the Veno-venous ECMO Expert Panel appointed in February 2016 by the national consultant on anesthesiology and intensive care.</ArticleTitle>
<Pagination>
<MedlinePgn>88-99</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5603/AIT.a2017.0028</ELocationID>
<Abstract>
<AbstractText>Extracorporeal Membrane Oxygenation (ECMO) has become well established technique of the treatment of severe acute respiratory failure (Veno-Venous ECMO) or circulatory failure (Veno-Arterial ECMO) which enables effective blood oxygenation and carbon dioxide removal for several weeks. Veno-Venous ECMO (V-V ECMO ) is a lifesaving treatment of patients in whom severe ARDS makes artificial lung ventilation unlikely to provide satisfactory blood oxygenation for preventing further vital organs damage and progression to death. The protocol below regards exclusively veno-venous ECMO treatment as a support for blood gas conditioning by means of extracorporeal circuit in adult patients with severe ARDS. V-V ECMO does not provide treatment for acutely and severely diseased lungs, but it enables patient to survive the critical phase of severe ARDS until recovery of lung function. Besides avoiding patients death from hypoxemia, this technique can also prevent further progression of the lung damage due to artificial ventilation. Recent experience of ECMO treatment since the outbreak of AH1N1 influenza pandemic in 2009, along with technical progress and advancement in understanding pathophysiology of ventilator-induced lung injury, have contributed to significant improvement of the results of ECMO treatment. Putative factors related to increased survival include patients retrieval after connecting them to ECMO, and less intensive anticoagulation protocols. The aim of presenting this revised protocol was to improve the effects of ECMO treatment in patients with severe ARDS, to enhance ECMO accessibility for patients who might possibly benefit from this treatment, to reduce time until patient's connection to ECMO, and to avoid ECMO treatment in futile cases. The authors believe that this protocol, based on recent papers and their own experience, can provide help and advice both for the centers which develop V-V ECMO program, and for doctors who will refer their patients for the treatment in an ECMO center.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lango</LastName>
<ForeName>Romuald</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardioanaesthesiology, Medical University of Gdańsk, Gdańsk, Poland. rlango@gumed.edu.pl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Szkulmowski</LastName>
<ForeName>Zbigniew</ForeName>
<Initials>Z</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Maciejewski</LastName>
<ForeName>Dariusz</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sosnowski</LastName>
<ForeName>Andrzej</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kusza</LastName>
<ForeName>Krzysztof</ForeName>
<Initials>K</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Poland</Country>
<MedlineTA>Anaesthesiol Intensive Ther</MedlineTA>
<NlmUniqueID>101472620</NlmUniqueID>
<ISSNLinking>1642-5758</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>142M471B3J</RegistryNumber>
<NameOfSubstance UI="D002245">Carbon Dioxide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>S88TT14065</RegistryNumber>
<NameOfSubstance UI="D010100">Oxygen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000776" MajorTopicYN="N">Anesthesiology</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002245" MajorTopicYN="N">Carbon Dioxide</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome, Adult</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055397" MajorTopicYN="N">Ventilator-Induced Lung Injury</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ARDS</Keyword>
<Keyword MajorTopicYN="N">ECMO</Keyword>
<Keyword MajorTopicYN="N">acute respiratory failure</Keyword>
<Keyword MajorTopicYN="N">extracorporeal membrane oxygenation</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>03</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2017</Year>
<Month>05</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>6</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>6</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2018</Year>
<Month>3</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28643320</ArticleId>
<ArticleId IdType="pii">VM/OJS/J/50864</ArticleId>
<ArticleId IdType="doi">10.5603/AIT.a2017.0028</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000399 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000399 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:28643320
   |texte=   Revised protocol of extracorporeal membrane oxygenation (ECMO) therapy in severe ARDS. Recommendations of the Veno-venous ECMO Expert Panel appointed in February 2016 by the national consultant on anesthesiology and intensive care.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:28643320" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1 

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021